An exceedingly rare entity: Mixed cellular type primary Hodgkin’s lymphoma of the parotid gland by Demet Yilmazer et al.
Albayrak et al. Hodgkin’s lymphoma of the parotis 533
J Clin Exp Invest   www.jceionline.org   Vol 3, No 4, December 2012
1 Dışkapı Yıldırım Beyazıt Education and Research Hospital, Department of Pathology, Ankara, Turkey
2 Dışkapı Yıldırım Beyazıt Education and Research Hospital, Department of Hematology, Ankara, Turkey
Correspondence: Murat Albayrak, 
Diskapi Yildirim Beyazit Hospital, Dept. Hematology, Ankara, Turkey E-mail: muratalbayrak71@yahoo.com
Received: 09.09.2012, Accepted: 11.12.2012
Copyright © JCEI / Journal of Clinical and Experimental Investigations 2012, All rights reserved
JCEI /   2012; 3 (4): 533-535
Journal of Clinical and Experimental Investigations   doi: 10.5799/ahinjs.01.2012.04.0216
CASE REPORT
An exceedingly rare entity: Mixed cellular type primary Hodgkin’s lymphoma of the 
parotid gland
Son derece nadir bir durum: Parotis bezinin miks sellüler tip primer Hodgkin lenfoması
Aynur Albayrak1, Murat Albayrak2, Ata Türker Arikök1, Tuba Dilay Kökenek Ünal1, Demet Yilmazer1
ÖZET
Parotis bezinin miks sellüler tip primer hodgkin lenfoması 
son derece nadir görülür. Biz burada 2 aydır olan ağrı-
sız preaurikular kitle ile başvuran 80 yaşında bir kadın 
hastayı sunduk. Sitolojik ve histomorfolojik bulgular miks 
sellüler tip hodgkin lenfoma ile uyumlu bulundu. Yaş ve 
komorbid hastalıklarından ötürü hastaya sadece radyo-
terapi verildi. Hastanın, tanıdan itibaren 12 aydır remis-
yonda takibi devam ediyor. Parotis bezinin Miks sellüler 
tip primer hodgkin lenfoması son derece nadirdir ve bu 
hastalığın  biyolojik  davranışı  ve  prognozu  araştırılmayı 
beklemektedir.
Anahtar kelimeler: Miks sellüler hodgkin lenfoma, paro-
tis, radyoterapi
ABSTRACT
Primary mixed cellularity Hodgkin’s lymphoma of the pa-
rotid gland is extremely rare. We report here an 80-year 
old woman who presented with a painless preauricular 
mass of two months duration. Cytological and histomor-
phological findings were consistent with mixed cellularity 
Hodgkin’s lymphoma. Due to the age and the presence 
of comorbid diseases, the patient only received radioth-
eraphy and has been in remission for 12 months since 
the initial diagnosis. Primary Mixed cellularity Hodgkin’s 
lymphoma of the parotid gland is extremely rare and the 
prognosis, in addition to the biologic behavior of this dis-
ease is yet to be evaluated. J Clin Exp Invest 2012; 3(4): 
533-535
Key words: Mixed cellularity Hodgkin’s lymphoma, pa-
rotid, radiotheraphy
INTRODUCTION
Lymphoma is a malignancy of lymphoid tissues. 
The vast majority of lymphomas occur within lymph 
nodes.  However,  it  can  present  in  an  extranodal 
site. Approximately 25% to 30% of cases of NHL 
and 1% of cases of HL will present as extranodal 
diseases.  The  majority  of  extranodal  lymphomas 
occur  in  the  gastrointestinal  tract,  and  head  and 
neck is the most common site. Walderyer’s ring is 
the most common site of origin within in the head 
and neck. Lymphomas involving the parotid gland 
are uncommon; they only account for 0,6% to 5% of 
all neoplasm and/or tumor-like lesions involving the 
parotid gland. The vast majority of parotid gland lym-
phomas are NHL. Incidence of primary Hodgkin’s 
lymphoma of the parotid gland is extremely rare 1-5 
and most of the reported cases are of lymphocyte 
predominant subtype.5 On the other hand, mixed 
cellularity type Hodgkin’s lymphoma is exceptional 
with only seven cases reported up to date.1-4 We re-
port here, to the best of our knowledge, the eighth 
primary, mixed cellularity type Hodgkin’s lymphoma 
of the parotid gland to contribute in part to a better 
understanding of the disease.
CASE REPORT
An 80-year-old woman presented with painless pre-
auricular mass with two months of duration. Previ-
ous medical history was unremarkable. Physical 
examination revealed a mass measuring 30x30 mm 
size in the lower region of the right parotid gland. 
The patient denied night sweats or weight loss. 
The patient was afebrile and no cervical, axillary or 
inguinal lymphadenopathy or organomegaly was 
present. Radiological study of the chest, abdomen 
and other areas of the cervical showed no addition-
al abnormalities. On computerized tomography, a 
solid lesion with hypodense areas in the center and 
contrast enhancing hyperdense areas at the periph-Albayrak et al. Hodgkin’s lymphoma of the parotis 534
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ery was observed. The lesion measured 30x20 mm. 
No abnormality was detected in bone marrow aspi-
ration and bone marrow trephine biopsy.
Clinically, benign tumors of the salivary gland 
such as a mixed tumor were suspected. Fine-needle 
aspiration (FNA) revealed no epithelial cell compo-
nent but lymphocytes and a small number of large 
multinucleated atypical cells which were highly sug-
gestive of HL were noted [Fig. 1]. Subsequently, a 
superficial parotidectomy was performed. Grossly 
the specimen consisted of a parotid gland which 
measured 50×40×20 mm in size. In cut section a 
fish  fleshy  enlarged  lymph  node  30x20  mm  was 
present in the normal parenchyma of the gland. Mi-
croscopic examination revealed a well-demarcated 
solid tumor without a fibrous capsule located in the 
parotid gland [Fig. 2]. The lesion was composed of a 
large number of eosinophils, plasma cells, lympho-
cytes and atypical mononuclear cells admixed with 
classic Reed-Sternberg cells [Fig. 3]. The sections 
were immunostained by streptavidin-biotin method 
with the following panel of antibodies: CD15 (Clone: 
Carb-3, DAKO), CD30 (Clone: Ber-H2, DAKO), CD 
45 (Clone: Uchl-1, DAKO), CD20 (Clone: L26, In-
vitrogen).  The  classic  Reed-Sternberg  cells  were 
positive for CD15 and CD30. Whereas, they were 
negative for CD45 and CD20. According to the crite-
ria which are described given at the literature (Table 
1), primary parotis gland lymphoma diagnosis was 
made.
With the findings above, a diagnosis of HL of 
parotid  gland  was  confirmed  and  the  tumor  was 
classified as mixed cellularity type. The patient was 
classified as Stage IB and was treated with only ra-
diotherapy and has been in remission for 12 months 
since the initial diagnosis.
Table 1. Criteria used to define primary parotid gland lymphoma.4,6
• Any lymphoma originating in either glandular lymph nodes or glandular parenchyma, regardless of its association 
with autoimmune disease or its subsequent stage: must be initial clinical manifestation of lymhoma
• Any lymphoma originating in glandular parenchyma as initial clinical manifestation of lymphoma
• Any lymphoma not associated with autoimmune disease, bening lymphoepithelial lesion, or myoepithelial sialadenitis
• Any lymphoma originating in glandular parenchyma not associated with autoimmune disease
• Any lymphoma originating either in glandular parenchyma or in glandular lymph node with invasion of parenchyma, 
in absence of detectable disease outside of parotid gland
• Any lymphoma originating in glandular parenchyma in absence of extraparotid involvement at time of diagnosis
Figure 1. Fine needle aspiration shows a binuclear clas-
sic giant cell with many lymphocytes. (MGG,x400)
Figure 2. Tumour separated from the normal parotid tis-
sue by a fibrous capsule. (H&E,X100)Albayrak et al. Hodgkin’s lymphoma of the parotis 535
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Figure 3. Histopathology of tumor showing Reed–Stern-
berg cells indicative of Hodgkin lymphoma. (H&E,x400)
DISCUSSION
Several criteria for a salivary gland lymphoma to 
be considered as primary has been reported up 
to date.4 WHO defines a lymphoma of the salivary 
gland as primary only if the bulk of the tumor is in 
the gland and the parenchyma is involved.5 Lym-
phoma  accounts  for  0.6-5%  of  all  parotid  gland 
tumors.  Non-Hodgkin’s  lymphoma  constitutes  the 
vast  majority  of  these  cases  (84%-97%).  On  the 
other hand, Hodgkin’s lymphoma only accounts for 
4% of all primary lymphomas of the salivary glands.5
Hodgkin’s  lymphoma  of  the  parotid  gland  is 
most commonly of lymphocyte predominant type. 
Whereas, mixed cellularity Hodgkin’s lymphoma of 
this region is exceptionally rare. We made a thor-
ough search of the literature to determine the cas-
es diagnosed as mixed cellularity type Hodgkin’s 
lymphoma in parotid gland. Among the reports, in 
which the subtype of the Hodgkin’s lymphoma was 
mentioned, we were able to determine only seven 
cases, with our case being the eighth one.1-4
The  diagnostic  accuracy  of  FNA  in  parotid 
gland masses is around 85-93.5%; However, due to 
the rarity of lymphomas in this region 3 and the pos-
sibility of not being able to see the classical Reed-
Sternberg cells in FNA biopsies, the diagnostic ac-
curacy of FNA in lymphomas is only 66%.4 Some 
cases  are  overlooked  and  diagnosed  as  reactive 
lymph nodes in parotid gland or as Warthin’s tumor.4 
Flow cytometry and immunohistochemical analysis 
are other diagnostic tools, but the definitive diagno-
sis, the decision of whether the lymphoma is nodal 
or parenchymal and subtyping can only be made by 
histological examination of the lesion.1-4 In our case 
although the FNA slides were highly suspicious of a 
Hodgkin’s lymphoma, the definitive diagnosis could 
be made by evaluating the histological sections. 
Due to the rarity of the lesion it is not possible to 
determine the biologic significance and prognosis of 
these cases; however, it is suggested that the lym-
phomas of the parotid gland have a more favorable 
prognosis than the ones in other sites. Moreover, 
primary Hodgkin’s lymphoma of the parotid gland 
has been reported to have a more favorable prog-
nosis than non-Hodgkin’s lymphomas.4
The treatment protocols for lymphomas of this 
region include chemotherapy and/or radiothera-
phy.1,4
In Hodgkin’s lymphomas of the parotid gland 
stage and age are considered to have more impact 
on prognosis than the histological subtype.4 How-
ever, coming up with a definitive conclusion on the 
prognosis  and  biologic  behavior  of  different  sub-
types of this lesion does not seem to be possible 
before evaluating the data in larger series.
In conclusion, we reported here an extremely 
rare variant of mixed cellularity type Hodgkin’s lym-
phoma primarily arising in the parotid gland with the 
hope that the case contributes to a better under-
standing of the disease.
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